Senators Collins, McCaskill, Stabenow Lead Bipartisan Group of Senators in Introducing Legislation to Prohibit “Gag Clauses” That Cause Consumers to Pay Higher Prices for Prescription Drugs

Washington, D.C. — Today, U.S. Senators Susan Collins (R-ME), Claire McCaskill (D-MO), and Debbie Stabenow (D-MI) led a bipartisan group of Senators in introducing two bills to remove barriers that prevent patients from paying the lowest possible price for prescription drugs.  The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act would prohibit health insurers and pharmacy benefit managers from using “pharmacy gag clauses” – an egregious practice that some companies use to conceal prices from patients at the pharmacy.


Senate Passes Senators Collins, McCaskill’s Bill to Protect Seniors from Scams

Washington, D.C. —The Senior $afe Act, a bipartisan bill authored by U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) to help protect American seniors from financial exploitation and fraud, cleared a key hurdle this evening by passing the Senate as part of a bipartisan banking reform package.  Their legislation previously passed the House of Representatives.



Collins, Tester Join Nationwide Public Schools Week Celebration

Washington, D.C. – From March 12 to 16, U.S. Senators Susan Collins (R-ME) and Jon Tester (D-MT) are joining students, teachers, and administrators from across the country to celebrate Public Schools Week, a nationwide initiative to highlight the important of America’s public education system.



Sens. Collins, Coons, Markey praise release of GAO technical assessment report in support of sustainable chemistry

Washington, D.C. – U.S. Senators Susan Collins (R-Maine), Chris Coons (D-Del.), and Ed Markey (D-Mass.) today praised the release of the GAO report entitled, “Technology Assessment: Chemical Innovation: Technologies to Make Processes and Products More Sustainable.”  GAO conducted this study in response to a request from Senators Collins, Coons, and Markey in May 2015.